|
Thursday, 26 June 2008 |
|
A new study has found that long-term use of Fosamax and other “bone-building” drugs can make it harder for a patient’s bones to heal properly. As a result, Fosamax users may be at an increased risk of a certain type of bone fractures. |
|
Read more...
|
|
|
Tuesday, 20 May 2008 |
|
A study of a new experimental osteoporosis drug found that it was significantly more effective at increasing bone density than Fosamax. The new study could eventually spell trouble for Fosamax, whose side effects include a painful condition known as osteonecrosis of the jaw. |
|
Read more...
|
|
|
Monday, 07 January 2008 |
|
The Food and Drug Administration has warned that patients taking Fosamax and other similar bone-building drug may develop severe muscle, joint and bone pain as a result of their treatment. The agency says that it is concerned that doctors may be overlooking these drugs as a possible cause of the disabling pain reported by some patients. |
|
Read more...
|
|
|
Saturday, 01 December 2007 |
|
A group of Fosamax lawyers have argued that a judge should grant class action status to the lawsuits they have filed against Merck & Co., the manufacturers of the bone-building drug. The lawyers say that by granting class-action status to the Fosamax lawsuits, it would give a jury an opportunity to decide whether the drug is hazardous to patients’ health and whether Merck was negligent in failing to properly warn them about the risk of Fosamax side effects. |
|
Read more...
|
|
|
Tuesday, 09 October 2007 |
|
A woman in Florida has filed a Fosamax lawsuit against Merck & Co., the manufacturer of the drug. Linda Secrest’s lawsuit alleges that she developed a painful jaw condition known as osteonecrosis of the jaw, or jaw necrosis, after taking Fosamax. |
|
Read more...
|
|
|
|
<< Start < Prev 1 2 Next > End >>
|
| Results 1 - 9 of 17 |